MedPath

The effect of probiotics supplementation in type 1 diabetic patients

Not Applicable
Recruiting
Conditions
Type 1 diabetes mellitus.
Type 1 diabetes mellitus
Registration Number
IRCT20201203049576N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

Having type 1 diabetes (fasting blood sugar greater than 125 mg / dL and HbA1C greater than 6.5% if confirmed by an endocrinologist)
Age over 7 and under 18 years
At least one year after developing type 1 diabetes
Willingness to participate in the study

Exclusion Criteria

Having liver, kidney, inflammatory, or immunodeficiency diseases
Taking antibiotics over the last two months
Consuming foods containing probiotics or probiotic supplements over the past month
Taking dietary supplements or non-steroid anti-inflammatory drugs during 1 month before the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath